Pirazolac

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePirazolac
Drug Alias Namepirazolacum吡拉唑酸pirazolac氯苯基氟苯基吡唑乙酸pirazolaco +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksKEGG